Skip to main content
SSIISS Innovations International InSell4.8·$3.71-5.84%
Open full analysis

SS Innovations International In (SSII) Stock Analysis

Recovery setup

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Devices

Sell if holding. Engine safety override at $3.71: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 3.8:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation; Below long-term trend.

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a... Read more

$3.71+57.4% A.UpsideScore 4.8/10#55 of 64 Medical Devices
QualityF-score6 / 9FCF yield-0.02%
Stop $3.52Target $5.95(analyst − 15%)A.R:R 3.8:1
Analyst target$7.00+88.7%1 analysts
Range unavailable (1 analysts)

Sell if holding. Engine safety override at $3.71: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 3.8:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 55. Score 4.8/10, moderate confidence.

Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: speculative.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.1 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)-63.0
Mkt Cap$756M
EV/EBITDA-159.8
Profit Mgn-20.7%
ROE-21.1%
Rev Growth116.8%
Beta0.56
DividendNone
Rating analysts1

Quality Signals

Piotroski F6/9MoatNarrow

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers·1 ceiling hit

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ps
0.0
Expensive valuation
Low model confidence on this dimension (20%).

Unprofitable operations — net margin -20.7%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Net Margin
0.0
Fcf Quality
0.0
Gross Margin
5.8
Moat
6.5
Piotroski F
6.7
Current Ratio
8.6
Cash-burning: FCF -0% of revenue

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
0.5
Quality Rank
2.4
Growth Rank
9.8
Industry growth leader

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.0
Bollinger
2.7
Support Resistance
5.1
Gap
6.0
GatesMomentum 5.3<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Momentum 5.3>=4.5A.R:R 3.8 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
55 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $3.22Resistance $4.37

Price Targets

$4
$6
A.Upside+60.4%
A.R:R3.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.1 < 4.0)

Earnings

We could not retrieve earnings history for SSII.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is SSII stock a buy right now?

Sell if holding. Engine safety override at $3.71: Quality below floor (3.1 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 3.8:1 is above the 1.5:1 BUY gate. Specifically: Below-average business quality; Rich valuation; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 55. Prior stop was $3.52. Score 4.8/10, moderate confidence.

What is the SSII stock price target?

Take-profit target: $5.95 (+57.4% upside). Prior stop was $3.52. Stop-loss: $3.52.

What are the risks of investing in SSII?

Quality below floor (3.1 < 4.0).

Is SSII overvalued or undervalued?

SS Innovations International In trades at a P/E of N/A (forward -63.0). TrendMatrix value score: 0.0/10. Verdict: Sell.

0
What does SS Innovations International In do?SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics...

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI – Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa – Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.

Related stocks: DCTH (Delcath Systems, Inc.) · BWAY (Brainsway Ltd.) · TCMD (Tactile Systems Technology, Inc) · ATEC (Alphatec Holdings, Inc.) · MOBI (Mobia Medical, Inc.)
Home Stocks SSII

Latest news

No recent news